Literature DB >> 33494421

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder.

Alessandro Pallucchini1, Marco Carli2, Marco Scarselli3, Icro Maremmani4,5,6,7, Giulio Perugi8.   

Abstract

A large amount of the current literature has focused on the characteristic symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. In contrast, less attention has been devoted to ADHD clinical subtypes in adult patients. We evaluated 164 consecutive adult ADHD (A-ADHD) outpatients using DSM-5 criteria and many specific rating scales and questionnaires. A principal component factor analysis was performed on clinical and symptomatological variables to describe potential clinical variants. We sought to determine different A-ADHD variants focusing on demographic and clinical features. A four-factor solution was identified, and patients were clustered, according to their z-score, in 4 subgroups. The first was marked out by Emotional Dysregulation (ED), the second by Substance Use (SU), the third by Core-ADHD Symptoms (Co-ADHD) and the fourth by Positive Emotionality (PE). Predominantly ED patients showed worse overall function, early treatment with antidepressants and a greater presence of borderline personality disorder than predominantly Co-ADHD patients. Predominantly SU patients reported high rates of bipolar disorder and severe general psychopathology. The PE factor was related to hyperthymic temperament and hypomania and showed a higher level of functioning. Females with A-ADHD showed a lower risk of being included in SU, and A-ADHD patients with co-occurring delayed sleep phase had less risk of being included in the SU factor than the prevailing Co-ADHD group. Our empirically based description of four clinical A-ADHD variants shows several aspects beyond the definition given by the DSM-5 diagnostic criteria.

Entities:  

Keywords:  attention deficit/hyperactivity disorder; emotional dysregulation; positive emotionality; substance user

Mesh:

Year:  2021        PMID: 33494421      PMCID: PMC7908530          DOI: 10.3390/ijerph18030922

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  82 in total

Review 1.  Distinguishing comorbidity and successful management of adult ADHD.

Authors:  J J Sandra Kooij; Michael Huss; Philip Asherson; Ron Akehurst; Kathleen Beusterien; Alexis French; Rahul Sasané; Paul Hodgkins
Journal:  J Atten Disord       Date:  2012-04-12       Impact factor: 3.256

2.  Reduced deactivation in reward circuitry and midline structures during emotion processing in borderline personality disorder.

Authors:  Bjoern Enzi; Stephan Doering; Cornelius Faber; Jens Hinrichs; Judith Bahmer; Georg Northoff
Journal:  World J Biol Psychiatry       Date:  2011-07-06       Impact factor: 4.132

3.  WHODAS 2.0 in community rehabilitation: a qualitative investigation into the validity of a generic patient-reported measure of disability.

Authors:  Stefan T Kulnik; Dimitra Nikoletou
Journal:  Disabil Rehabil       Date:  2013-04-15       Impact factor: 3.033

4.  The Child Behavior Checklist-Pediatric Bipolar Disorder profile predicts a subsequent diagnosis of bipolar disorder and associated impairments in ADHD youth growing up: a longitudinal analysis.

Authors:  Joseph Biederman; Carter R Petty; Michael C Monuteaux; Margaret Evans; Tiffany Parcell; Stephen V Faraone; Janet Wozniak
Journal:  J Clin Psychiatry       Date:  2009-04-21       Impact factor: 4.384

Review 5.  Antidepressants in bipolar disorder: the case for caution.

Authors:  S Nassir Ghaemi; Douglas J Hsu; Federico Soldani; Frederick K Goodwin
Journal:  Bipolar Disord       Date:  2003-12       Impact factor: 6.744

6.  The development of emotion regulation and dysregulation: a clinical perspective.

Authors:  P M Cole; M K Michel; L O Teti
Journal:  Monogr Soc Res Child Dev       Date:  1994

7.  Changes in the Definition of ADHD in DSM-5: Subtle but Important.

Authors:  Jeffery N Epstein; Richard E A Loren
Journal:  Neuropsychiatry (London)       Date:  2013-10-01

8.  Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions.

Authors:  K B Wells; J M Golding; M A Burnam
Journal:  Gen Hosp Psychiatry       Date:  1989-09       Impact factor: 3.238

9.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

Authors:  K Brookes; X Xu; W Chen; K Zhou; B Neale; N Lowe; R Anney; R Aneey; B Franke; M Gill; R Ebstein; J Buitelaar; P Sham; D Campbell; J Knight; P Andreou; M Altink; R Arnold; F Boer; C Buschgens; L Butler; H Christiansen; L Feldman; K Fleischman; E Fliers; R Howe-Forbes; A Goldfarb; A Heise; I Gabriëls; I Korn-Lubetzki; L Johansson; R Marco; S Medad; R Minderaa; F Mulas; U Müller; A Mulligan; K Rabin; N Rommelse; V Sethna; J Sorohan; H Uebel; L Psychogiou; A Weeks; R Barrett; I Craig; T Banaschewski; E Sonuga-Barke; J Eisenberg; J Kuntsi; I Manor; P McGuffin; A Miranda; R D Oades; R Plomin; H Roeyers; A Rothenberger; J Sergeant; H-C Steinhausen; E Taylor; M Thompson; S V Faraone; P Asherson
Journal:  Mol Psychiatry       Date:  2006-08-08       Impact factor: 15.992

10.  Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features.

Authors:  Vincenza Spera; Alessandro Pallucchini; Marco Maiello; Marco Carli; Angelo G I Maremmani; Giulio Perugi; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2020-05-17       Impact factor: 3.390

View more
  1 in total

1.  Re-Thinking the Mediating Role of Emotional Valence and Arousal between Personal Factors and Occupational Safety Attention Levels.

Authors:  Jiaming Wang; Pin-Chao Liao
Journal:  Int J Environ Res Public Health       Date:  2021-05-21       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.